DNONCE TECHNOLOGY Key Highlights • Significant improvement in Profit Before Tax (“PBT”) from loss of RM3.34 million in 1H Year-to-date (“YTD”) 30 June 2019 to RM2.40 million, an increase of RM5.74 million or 172% for Financial Year Ended 30 April 2020 (“FYE 30 April 2020”). • Noteworthy surge in revenue, average monthly sales for July 2019 till April 2020 was RM14.6 million compared with January 2019 till June 2019 of RM13.3 million representing a 9.8% increase, even though March and April sales were impacted by the Covid-19 induced MCO • Three consecutive profitable quarters with FYE PBT of RM2.40 million signifying 9 straight months of profit until April since the new management took over the running of the Company. D’nonce Technology Bhd (“D’nonce” or “the Group”) (“7114”), today announced its interim financial results for the sixth quarter (“Q6”) and 16-month consolidated financial results for its Financial Year Ended 30 April 2020 (“FYE 30 April 2020”). DNONCE is a diversified engineering solutions provider, serving customers in the semiconductor, automotive, medical/healthcare, data storage hardware and consumer electronics industries with overseas subsidiaries in Thailand. In mid-July 2019, D’nonce had installed a new Board of Directors and management, led by Mr. Tho Yow Yin as CEO. Under the new leadership. DNONCE embarked on costcutting measures and redirected their focus to expand the Group’s growth in value-added businesses. These efforts have borne positive results as reflected in its financial performance since July 2019 to 30 April 2020. D’nonce recorded a revenue of RM225 million for the FYE 30 April 2020, of which from 1 July 2019 to 30 April 2020, the Group recorded an average monthly revenue of RM14.6 million as compared to an average monthly revenue of RM13.3 million from 1 January 2019 to 30 June 2019, representing a 9.8% improvement in sales, despite the MCO which impacted operations in March and April 2020. The significant increment of the revenue was partly contributed by the surge in demand from customers in the healthcare industry mainly due to the Covid-19 outbreak as D’nonce provides essential support to the glove industry in Southern Thailand and also supplies injection molded ventilator parts from their factory in Prai, Pulau Pinang. Simultaneously, DNONCE continued to showcase a healthy and growing PBT having recorded a PBT of RM2.40 million for the Financial Period Ended 30 April 2020 reflecting a turnaround of RM5.74 million or 172% growth over the 1H Loss Before Tax of RM3.34 million. With the exception of Q6 FY2020 (which consisted of only 1 month), the Group achieved three consecutive quarters in the black (cumulative PBT of RM5.74 million from 1 July 2019 to 30 April 2020) - after losses earlier in the financial year throughout the first two quarters (cumulative Loss Before Tax of RM3.34 million from 1 January 2019 to 30 June 2019).
This is the result of the DNONCE Management’s continuous prudence in managing its expenses while expanding revenue, resulting in the highest level of operational efficiency and also the continuous growth of its business. As of 30th April 2020 the Group has generated a positive cash flow of RM8.16 million from operating activities and have cash and bank balances of RM32.5 million. For the full FYE 30 April 2020, D’nonce recorded a Profit After Tax of RM0.73 million (after the non-cash adjustment from the revaluation of properties deficit of RM0.45 million) in spite of the net losses recorded for Financial Period Ended 30 June 2019. Notwithstanding the challenging environment, DNONCE is cautiously optimistic of its business with the expectation of continued strong demand for its supplies to the medical and health sectors as well as the positive demand from the electronic technology sector moving forward. DNONCE has active initiatives underway to enhance its overall organisational effectiveness. These initiatives should increase productivity and cost efficiency while also helping to realise scale economies as Dnonce continues to grow its commercial opportunities.
两大利好围绕DNONCE!! 1)Provides Essential Support (Glove Industry) Southern Thailand
2) Injection Molded Ventilator Parts (Prai, Pulau Pinang)
told you all.. patience is virtue... now go to opensys... its the next play.. rmb.. i said it here first. >>>>>>>>>> asianbengraham this is a silent counter that nobody knows... collect while u can... 09/08/2020 1:59 PM
maksudnya, Dnonce masih belum mendapat 100% perhatian daripada mata orang lain. Hari itu akan LIMIT UP bila mereka MEMBELI secara mengejutkan dalam Vol yang TINGGI. SABAR...
Got some news from my telegram feed tot its worthy to share here from stock-bit. Seems legit some of their research.
$DNONCE - Major beneficiaries of strong global demand in glove as they supply packaging solutions to major glove manufacturers in Thailand. Sustainable turnaround year ahead under a new management.
We laid out 7 REASONS Why DNONCE can potentially be a good investment.
"1) Management mentioned they're currently experiencing very strong orders and are operating at maximum capacity, in tandem with the robust demand for gloves... From its recent corporate presentation, and google map, we can guess with high accuracy that $TOPGLOV Thailand and Sri Trang Glove are their clients...
4) Blackstream Investment - whom had taken a major role in the shake up, had an average price of RM0.45...
Currently projecting a base case RM 15m of net profit for FY2021, which translate into 5.7c eps FY2021. Extrapolating that into 15x PE based on $MUDA valuation, A loose and moving Intrinsic Value could potentially be at RM 0.86."
This one not much support. I remember once the share shoot up for no reason The day after, it freefall so fast. Luckily I still hold cause too much lost already. Now the price have break previous record but the volume not that big, maybe investor lose trust? Who knows.
Reading the latest Bursa announcements and the last QR report, it seems that the QR results are coming out soon...with the principal officer now just announcing his intention to deal during closed period, the result will need to be released within 30 days according to Bursa listing rules...
Reading the corporate presentation by the CEO and the company, this coming QR result next month is foreseen to be a massive exponential gain from the last quarter...just like gloves. but compared to gloves, this stock price is still relatively undervalued...the results must be very good for the company to want to urgently announce their results and I suspect a massive upside is awaiting. Recommended for short-medium term gain...the good thing to like about this stock is that it has very strong fundamentals backed by a solid quarter-to-quarter profit increase and with the exponential ride with the gloves/healthcare, this company has more potential to make more profits... at the current price, it is indeed a rare gem.
very impressive Annual Report released. growth areas clearly highlighted, giving a glimpse of the next QR result to be released soon next month...truly a gem.
This stock is being primed for a shoot up...been following the price action last few weeks. a lot of collection, moving slowly but steadily. not many sellers. people who buy a firm believers of this stock...definitely a solid one.
Post a Comment
People who like this
New Topic
You should check in on some of those fields below.
Title
Category
Comment
Confirmation
Click Confirm to delete this Forum Thread and all the associated comments.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
asianbengraham
152 posts
Posted by asianbengraham > 2020-08-18 16:55 | Report Abuse
SHOW TIME